Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Breast Neoplasms 1228Neoplasms 1037Carcinoma, Non-Small-Cell Lung 757Prostatic Neoplasms 695Colorectal Neoplasms 597Lung Neoplasms 578Pancreatic Neoplasms 400Leukemia, Myeloid, Acute 398Neoplasm Metastasis 391Multiple Myeloma 373Ovarian Neoplasms 372Stomach Neoplasms 319Carcinoma, Hepatocellular 302Melanoma 283Brain Neoplasms 280Recurrence 278Squamous Cell Carcinoma of Head and Neck 269Head and Neck Neoplasms 239Glioblastoma 235Endometrial Neoplasms 235Triple Negative Breast Neoplasms 229Precursor Cell Lymphoblastic Leukemia-Lymphoma 225Lymphoma 225Uterine Cervical Neoplasms 224Sarcoma 202Hematologic Neoplasms 201Urinary Bladder Neoplasms 197Esophageal Neoplasms 192Carcinoma, Renal Cell 190Lymphoma, Non-Hodgkin 177

Interventions

durvalumab 1Probiotics 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Limited Stage Small Cell Lung Cancer × 1 year × Clear all
NCT06773910 2026-04-22

TIGOS-LS

SCRI Development Innovations, LLC

Phase 2 Recruiting
250 enrolled
Thoracic

Limited Stage Small Cell Lung Cancer

NCT06943235 2026-02-11

Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)

Fudan University

Phase 2 Recruiting
60 enrolled
Thoracic

Limited Stage Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡